1872
E. V. Boltukhina et al.
PAPER
1-Bromo-5,5-dimethyl-11-oxo-5,6,6a,11-tetrahydroisoindo-
lo[2,1-a]quinoline-10-carboxylic Acid (14e)
16c
13C NMR (DMSO-d6, 100.6 MHz): d = 166.3 (s) and 165.5 (s)
1
13C NMR (DMSO-d6, 100.6 MHz): d = 165.8 and 164.9 (C=O),
148.4 (s), 142.4 (s), 133.2 (d), 132.4 (s), 131.6 (d), 130.8 (d), 130.2
(s), 128.2 (d), 127.8 (s), 126.8 (d), 126.0 (d), 118.0 (s), 56.7 (C-6a),
44.9 (t, C-6), 40.5 (d, C-5), 32.0 and 29.7 (CH3-5).
(CO2H and NC=O), 159.5 (d, JC,F = ~242 Hz, C-3), 146.4 (s),
3
135.70 (d, JC,F = 7.2 Hz, C-4a), 133.1 (d), 131.5 (d), 130.5 (d,
4JC,F = 2.2 Hz, C-11b), 129.7 (s), 128.9 (s), 126.6 (d), 122.06 (d,
3JC,F = 8.3 Hz, C-1), 116.1 (d, 2JC,F = 22.6 Hz), 113.7 (d, 2JC,F = 22.5
Hz), 55.3 (d, C-6a), 33.3 (t, C-6), 30.7 (d, C-5), 23.9 (q, CH3-5).
1-Fluoro-5,5-dimethyl-11-oxo-5,6,6a,11-tetrahydroisoindo-
lo[2,1-a]quinoline-10-carboxylic Acid (14f)
19F NMR (DMSO-d6, 376.5 MHz, external standard: 0.2 M C6H5F
in DMSO): d = –3.71.
13C NMR (DMSO-d6, 100.6 MHz): d = 165.4 (s) and 165.0 (s)
1
(CO2H and NC=O), 154.32 (d, JC,F = 251.4 Hz, C-3), 147.8 (s),
1-Chloro-5-methyl-11-oxo-5,6,6a,11-tetrahydroisoindolo[2,1-
a]quinoline-10-carboxylic Acid (15d)
140.6 (br d, C-4a), 132.8 (d), 130.9 (d), 130.0 (s), 127.8 (s), 127.08
3
4
(d, JC,F = 8.1 Hz, C-3), 126.4 (d), 122.5 (d, JC,F = 2.7 Hz, C-4),
120.85 (d, 2JC,F = 12.7 Hz, C-11b), 114.5 (d, 2JC,F = 19.9 Hz, C-2),
55.9 (d, C-6a), 44.4 (t, C-6), 33.9 (d, C-5), 32.2 (q) and 29.9 (q,
CH3-5).
13C NMR (DMSO-d6, 100.6 MHz): d = 165.7 and 165.0 (C=O),
148.3 (s), 137.9 (s), 133.2 (d), 131.7 (s), 130.9 (d), 130.2 (s), 128.5
(d), 128.3 (s), 127.72 (d), 127.65 (s), 126.6 (d), 126.4 (d), 58.8 (C-
6a), 38.5 (C-6), 31.3 (C-5), 21.1 (CH3-5).
19F NMR (DMSO-d6, 376.5 MHz, external standard: 0.2 M C6H5F
in DMSO): d = 0.60.
16d
13C NMR (DMSO-d6, 100.6 MHz): d = 165.7 and 165.0 (C=O),
148.5 (s), 140.1 (s), 133.7 (s), 133.3 (d), 132.1 (s), 130.9 (d), 128.6
(s), 128.2 (d), 128.03 (d), 127.96 (s), 126.9 (d), 125.9 (d), 56.4 (C-
6a), 37.3 (C-6), 29.7 (C-5), 21.0 (CH3-5).
3-Chloro-5-methyl-11-oxo-5,6,6a,11-tetrahydroisoindolo[2,1-
a]quinoline-10-carboxylic Acid (15a)
13C NMR (DMSO-d6, 100.6 MHz): d = 166.1 and 165.6 (C=O),
145.9 (s), 134.7 (s), 133.3 (s), 133.1 (d), 131.4 (d), 129.7 (s), 129.4
(s), 128.5 (s), 127.6 (d), 126.7 (d), 126.4 (d), 121.71 (d), 59.1 (C-
6a), 35.5 (C-6), 31.0 (C-5), 20.5 (CH3-5).
1-Bromo-5-methyl-11-oxo-5,6,6a,11-tetrahydroisoindolo[2,1-
a]quinoline-10-carboxylic Acid (15e)
13C NMR (DMSO-d6, 100.6 MHz): d = 165.7 and 165.0 (C=O),
148.49 (s), 138.6 (s), 133.2 (s), 133.2 (d), 131.7 (d), 131.0 (d), 130.2
(s), 128.2 (d), 127.6 (s), 127.0 (d), 126.6 (d), 118.1 (s), 58.8 (C-6a),
38.3 (C-6), 31.6 (C-5), 21.2 (CH3-5).
16a
13C NMR (DMSO-d6, 100.6 MHz): d = 166.1 and 165.6 (C=O),
146.3 (s), 135.2 (s), 133.1 (d), 133.0 (s), 131.2 (d), 129.8 (s), 129.0
(s), 128.6 (s), 127.6 (d), 126.7 (d), 126.4 (d), 121.66 (d), 55.0 (C-
6a), 33.1 (C-6), 30.4 (C-5), 23.8 (CH3-5).
16e
13C NMR (DMSO-d6, 100.6 MHz): d = 165.9 and 165.7 (C=O),
148.55 (s), 141.1 (s), 134.0 (s), 133.4 (d), 131.3 (d), 131.0 (d), 130.0
(s), 128.6 (d), 128.0 (s), 127.1 (d), 125.9 (d), 118.6 (s), 56.9 (C-6a),
37.4 (C-6), 29.7 (C-5), 19.9 (CH3-5).
3-Bromo-5-methyl-11-oxo-5,6,6a,11-tetrahydroisoindolo[2,1-
a]quinoline-10-carboxylic Acid (15b)
13C NMR (DMSO-d6, 100.6 MHz): d = 166.4 and 165.2 (C=O),
146.0 (s), 135.6 (s), 135.2 (s), 133.0 (d), 131.6 (d), 130.4 (d), 130.0
(s), 129.9 (s), 129.6 (d), 126.3 (d), 122.1 (d), 117.7 (s), 59.3 (C-6a),
36.0 (C-6), 31.0 (C-5), 20.6 (CH3-5).
1-Fluoro-5-methyl-11-oxo-5,6,6a,11-tetrahydroisoindolo[2,1-
a]quinoline-10-carboxylic Acid (15f)
13C NMR (DMSO-d6, 100.6 MHz): d = 165.7 (s) and 165.2 (s)
1
16b
(CO2H and NC=O), 154.7 (d, JC,F = 252.6 Hz, C-3), 147.8 (s),
13C NMR: Not recorded on account of the extremely low concentra-
tion of the solution.
136.5 (br d, C-4a), 133.1 (d), 131.2 (d), 130.1 (s), 127.9 (s), 127.25
3
4
(d, JC,F = 8.1 Hz, C-3), 126.7 (d), 123.27 (d, JC,F = 2.3 Hz, C-4),
121.96 (d, 2JC,F = 12.8 Hz, C-11b), 114.5 (d, 2JC,F = 20.2 Hz, C-2),
58.6 (d, C-6a), 38.4 (t, C-6), 30.7 (d, C-5), 20.9 (q, CH3-5).
3-Fluoro-5-methyl-11-oxo-5,6,6a,11-tetrahydroisoindolo[2,1-
a]quinoline-10-carboxylic Acid (15c)
19F NMR (DMSO-d6, 376.5 MHz, external standard: 0.2 M C6H5F
in DMSO-d6): d = 0.58.
13C NMR (DMSO-d6, 100.6 MHz): d = 166.1 (s) and 165.5 (s)
1
(CO2H and NC=O), 159.5 (d, JC,F = 242.6 Hz, C-3), 146.0 (s),
3
135.30 (d, JC,F = 7.2 Hz, C-4a), 133.1 (d), 131.67 (d), 130.85 (d,
16f
4JC,F = 2.2 Hz, C-11b), 129.6 (s), 128.8 (s), 126.6 (d), 122.06 (d,
3JC,F = 8.3 Hz, C-1), 114.5 (d, 2JC,F = 23.0 Hz), 113.5 (d, 2JC,F = 22.4
Hz), 59.4 (d, C-6a), 35.7 (t, C-6), 31.2 (d, C-5), 20.6 (q, CH3-5).
13C NMR: Not recorded on account of the extremely low concentra-
tion of the solution.
19F NMR (DMSO-d6, 376.5 MHz, external standard: 0.2 M C6H5F
in DMSO-d6): d = 0.41.
19F NMR (DMSO-d6, 376.5 MHz, external standard: 0.2 M C6H5F
in DMSO): d = –3.10.
Synthesis 2005, No. 11, 1859–1875 © Thieme Stuttgart · New York